Abstract
Cytotoxic T cells (CTL) are known to recognize small peptide fragments of cytoplasmic proteins bound to major histocompatibility complex (MHC) class I molecules on cell surfaces. Recent work indicates that tumor antigens are processed and presented in a manner similar to viral antigens. Identification of the peptides recognized by tumor-specific CTL would provide valuable information about their parent proteins, as well as allowing for the development of recombinant antigen-specific tumor vaccines. While highly represented MHC-bound peptides have been routinely purified by reversed-phase HPLC for Edman degradation sequencing, identification and sequencing of infrequent peptides that represent the biologically relevant targets of tumor-specific CTL have proved elusive. We have combined matrix-assisted laser desorption/ionization mass spectrometry with on-slide exopeptidase digestion to successfully identify and directly sequence a model tumor-specific peptide antigen derived from an integrated viral gene. The enhanced sensitivity of this technique (femtomolar range) allows for the sequencing of specific MHC-bound peptides derived from as few as 1 × 109 cells. © 1995 Academic Press, Inc.
Cite
CITATION STYLE
Woods, A. S., Huang, A. Y. C., Cotter, R. J., Pasternack, G. R., Pardoll, D. M., & Jaffee, E. M. (1995). Simplified high-sensitivity sequencing of a major histocompatibility complex class i-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry. Analytical Biochemistry, 226(1), 15–25. https://doi.org/10.1006/abio.1995.1185
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.